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ABSTRACT
Colicin E5 is a novel Escherichia coli ribonuclease
that specifically cleaves the anticodons of tRNA
Tyr,
tRNA
His, tRNA
Asn and tRNA
Asp. Since this activity
is confined to its 115 amino acid long C-terminal
domain (CRD), the recognition mechanism of
E5-CRD is of great interest. The four tRNA sub-
strates share the unique sequence UQU within their
anticodon loops, and are cleaved between Q
(modified base of G) and 30 U. Synthetic minihelix
RNAs corresponding to the substrate tRNAs were
completely susceptible to E5-CRD and were cleaved
in the same manner as the authentic tRNAs. The
specificity determinant for E5-CRD was YGUN at
 1t o13 of the ‘anticodon’. The YGU is absolutely
required and the extent of susceptibility of minihe-
lices depends on N (third letter of the anticodon)
in the order A . C . G . U accounting for the order
of susceptibility tRNA
Tyr . tRNA
Asp . tRNA
His,
tRNA
Asn. Contrastingly, we showed that GpUp is
the minimal substrate strictly retaining specificity
to E5-CRD. The effect of contiguous nucleotides is
inconsistent between the loop and linear RNAs,
suggesting that nucleotide extension on each side
of GpUp introduces a structural constraint, which is
reduced by a specific loop structure formation that
includes a 50 pyrimidine and 30 A.
INTRODUCTION
Colicins are plasmid-encoded toxins that kill Escherichia coli
cells not harbouring the same or a cognate plasmid. The
modes of killing have long been divided into three classes:
formation of ion channels in the inner membrane, deoxyri-
bonuclease (DNase) activity and ribonuclease (RNase)
activity (1,2). The DNase-type colicins nonspeciﬁcally cleave
the genomic DNA of sensitive cells (3–5), and the RNase-
type colicins inhibit protein synthesis of sensitive cells by
cleaving a speciﬁc site near the 30 end of 16S rRNA (6–8).
Colicin E5 inhibits protein synthesis by speciﬁcally
cleaving tRNATyr, tRNAHis, tRNAAsn and tRNAAsp of sensi-
tive E.coli cells; this led to the introduction of the fourth type
of colicin ‘tRNase’ (9). Colicin E5 cleaves these tRNAs
between the 34th queuosine (Q) and 35th uridine (U) that
correspond to the ﬁrst and second letters of the anticodon tri-
plets, yielding a 20,30-cyclic phosphate and a 50-OH terminus.
Q is a nucleoside with a unique base, namely, queuine.
Queuine is a highly modiﬁed guanine (G) base that is widely
found at the above-mentioned position in the above four
tRNA species in prokaryotes and eukaryotes (10–13). This
modiﬁed base is introduced by a base exchange reaction of
the precursor tRNA, which is catalysed by tRNA-guanine
transglycosylase (TGT) (14). Although Q is a nucleoside
unique to the substrate tRNAs of both colicin E5 and TGT,
colicin E5 also kills TGT-defective E.coli cells (15) whose
tRNAs possess a G instead of the Q; in fact, colicin E5
cleaves Q-deﬁcient tRNA
Tyr, tRNA
His, tRNA
Asn and tRNA
Asp
both in vivo and in vitro (9) (data not shown). Thus, the base
modiﬁcation unique to colicin E5-sensitive tRNAs does not
appear to be recognized by colicin E5.
Then, how does colicin E5 distinguish the target tRNAs
from a large number of cellular RNAs including other tRNA
molecules? The active domain of colicin E5 C-terminal ribo-
nuclease domain (CRD) is composed of only 115 amino acids;
this size is comparable with those of RNase A and RNase T1.
However, the substrate speciﬁcity of E5-CRD is quite differ-
ent from that of RNase A or RNase T1 that recognizes only
a single pyrimidine or G (16). Moreover, the cleavage by
E5-CRD is speciﬁc to anticodon loops; this suggests that
its recognition mechanism is more complicated than that of
RNase A and RNase T1. E5-CRD shows no sequence homo-
logy with traditional RNases and also lacks a catalytic His that
is essential for these RNases; hence, the unique interaction of
E5-CRD with RNA is of considerable interest to researchers.
The molecular size of E5-CRD is only approximately half
those of tRNAs; this suggests that E5-CRD recognizes only
limited portions of tRNAs to distinguish the target tRNAs
from other tRNAs. Since all E5-CRD-sensitive tRNAs con-
tain a unique sequence UQU (or UGU in the precursors of
these tRNAs) and are cleaved between the Q and the second
U, we considered this UQU sequence as a candidate sequence
that is recognized by E5-CRD. In this study, we determined
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synthetic anticodon arms and linear RNAs as substrates,
and discussed the recognition mechanism of E5-CRD from
the viewpoint of the target substrate structure.
MATERIALS AND METHODS
Materials
T4 polynucleotide kinase (Toyobo, Osaka) and [g-
32P]ATP
(NEN Life Science Products, Inc., Boston, MA) were used to
label the 50 end of the substrates. Ribonuclease T1 was pur-
chased from Sigma (St Louis, MO). Alkaline phosphatase
(E.coli A19; TaKaRa, Tokyo) was used to remove the 50-
monophosphate from in vitro-transcribed RNAs. We prepared
a plasmid pTO502 to produce E5-CRD and the wild-type
inhibitor protein (ImmE5) because the previously reported
plasmid pTO501 (9) had a point mutation in the immE5
gene. The methods used for overexpression and puriﬁcation
of E5-CRD and ImmE5 were as described previously (9).
E5-CRD was stored in 20 mM sodium phosphate buffer
(pH 7.0) containing 50% glycerol at  20 C.
In vitro transcription, purification and
50 labelling of minihelices
‘Minihelices’ (MHs) corresponding to the tRNA anticodon
arms were prepared as described previously (17) by in vitro
transcription using His-tagged T7 RNA polymerase provided
by Dr Tsutomu Suzuki (University of Tokyo). In a typical
procedure, 550 pmol of a synthetic 17mer DNA for the T7
promoter sequence is annealed to a synthetic 34mer template
DNA (450 pmol), half of which is complementary to a 17mer
anticodon arm. The T7 RNA polymerase barely initiates
transcription with C and prefers a GG sequence as the initia-
tion sequence (17). Among the tRNAs of interest, C is the
start base of the 50 end of the anticodon arm of both tRNA
His
and tRNA
Asp; hence, a set of 19mer MHs was also prepared
by adding GG to the 50 end of 17mer MHs. Each semi-duplex
obtained was mixed with 1 ml of reaction buffer comprising
40 mM Tris–HCl, pH 8.0, 14 mM MgCl2, 5 mM DTT, 1 mM
spermidine (Sigma), 2 mM of each NTP, 20 mM 50-GMP,
1 U/ml of inorganic pyrophosphatase from bakers yeast
(Sigma) and 50 mg/ml of BSA (Roche, Basel). The His-
tagged T7 RNA polymerase (20 ml) was added directly
from the puriﬁcation column, followed by incubation for
1 h and then supplemented with 20 ml of the T7 RNA poly-
merase and further incubated for 1 h. On performing this
method, MHs with 50-monophosphate were obtained. The
reaction was stopped by the addition of an equal volume of
2· loading solution (9 M urea, 0.02% bromophenol blue
and 0.02% xylene cyanol), followed by direct application
to a 20% preparative polyacrylamide gel containing TBE
buffer (90 mM Tris–borate and 1 mM EDTA) and 7 M
urea. The MHs were visualized by the UV-shadowing method
and eluted from the gel. They were then 50 end-labelled with
[g-
32P]ATP and T4 polynucleotide kinase after treatment
with alkaline phosphatase (TaKaRa).
Determination of the extent of cleavage using MHs
The cleavage reaction mixture comprised 20 mM Tris–HCl,
pH 8.5, 50 mM NaCl, 100 mg/ml BSA and 4 mM of a MH.
E5-CRD was added to this reaction mixture to yield a ﬁnal
concentration of 0.2 nM, and the mixture was then incubated
at 37 C. The MH used here contained a trace amount of
50 end-labelled MH. At intervals, 10 ml of the solution was
withdrawn and mixed with an equal volume of 2· loading
solution. The cleavage of the MHs was analysed by electro-
phoresis of the mixtures on a 20% polyacrylamide gel
containing 7 M urea and TBE buffer, and then the gel was
brought in contact with an imaging plate (FUJI FILM).
The imaging plate was then analysed by a FLA-3000 (FUJI
FILM) for visualization of the mobility pattern. Subse-
quently, radioactivity of the two bands—the intact MH and
50 end sequence of the cleavage products—was quantiﬁed.
The extent of the cleavage was calculated using the following
formula: extent of reaction (%) ¼ (50 end of the cleaved frag-
ment) · 100/(intact MH + 50 end of the cleaved fragment).
Oligonucleotide analysis
Oligonucleotides, dimers to tetramers, were chemically syn-
thesized by Genset (France). GpUp was purchased from
SIGMA. ApUp, GpCp and UpGp were provided by
Dr Kazuya Nishikawa (Gifu University). These oligonu-
cleotides were puriﬁed by reversed-phase high-performance
liquid chromatography (HPLC) on an ODS-3 column
(4.6 · 250 mm; GL Sciences) equilibrated with 100 mM tri-
ethylamine acetate buffer, pH 7.0, followed by elution with a
linear gradient of acetonitrile. The puriﬁed oligonucleotides
were then lyophilized and dissolved in milli-Q water. To
identify the reaction products from GpUp with E5-CRD,
several authentic oligonucleotides were mixed and run on
the reversed-phase column.
Determination of kinetic constants of E5-CRD
depending on various pH conditions with GpUp
The reaction was performed in a 1 cm path-length cuvette
containing 20 mM of Tris–HCl ranging from pH 7.5 to 9.5,
50 mM NaCl and 50 mg/ml BSA. The reaction mixture
was incubated with 21–78 mM of GpUp and 276–322 pM
of E5-CRD incubated at 25 C. E5-CRD (20 ml) was added,
and the increase in absorbance at 275 nm was monitored
using the DU-65 spectrometer (Beckman). The molar extinc-
tion coefﬁcient of GpUp used was 1150 (M
 1 cm
 1)a t
275 nm. Initial velocities were calculated from the plot
where the extent of reaction increased linearly against time.
The kcat and Km values with GpUp as the substrate were
determined from the [S]0   [S]0/v plot at various pH.
Determination of kinetic constants of E5-CRD with
oligoribonucleotides
To determine the kinetic constants with oligoribonucleotides,
3 ml of E5-CRD, ranging in concentration from 304.9 to
1524.4 pM, was added to 197 ml of the reaction buffer. The
ﬁnal reaction mixture comprises 20 mM Tris–HCl, pH 8.5,
50 mM NaCl, 100 mg/ml BSA and various amounts of oligo-
nucleotides. The concentration of each oligonucleotide
added was as follows: GpUp, 6.0–145.5 mM; UpGpU,
12.8–770.0 mM; UpGpUp, 25.4–254.0 mM; GpUpA, 36.0–
228.0 mM; UpGpUpA, 37.1–307.4 mM and ApGpUpA,
30.6–275.4 mM. After the addition of E5-CRD, a 90 ml
aliquot was immediately taken and mixed with one-third
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ture was incubated at 37 C until the extent of the reaction
reached 10–15%. At this time, acetic acid was added to
another 90 ml aliquot of the reaction mixture. These two sam-
ples were applied to an ODS-3 column (4.6 · 150 mm; GL
Sciences), and then the peak areas of the intact substrate
were measured. These values were then converted to the
initial and post-reaction amounts of the intact substrate, and
the initial velocity of each cleavage reaction was calculated.
The kinetic constants were determined according to a previ-
ously published program (18) based on more than 16 initial
velocities measured at various substrate concentrations.
Since the amount of ApGpUpA available was limited, the
reaction volume with ApGpUpA was set at 100 ml. The
volumes in the following steps were also decreased to half;
however, no difference was observed when compared with
the reaction using a volume of 200 ml.
RESULTS
Cleavage of MHs by E5-CRD
We assumed that E5-CRD distinguishes the target tRNAs
from other tRNAs by direct recognition of the UQU sequence
in the anticodon loop. Then, we prepared a series of short
17mer RNAs referred to as MHs corresponding to the
anticodon arms of an E5-CRD-sensitive tRNA
Tyr and an
E5-CRD-resistant tRNA
Lys as well as their variants
(Figure 1). The MHs were named, e.g. XMH is the MH
mimicking the anticodon arm of the tRNA for amino acid
X. The anticodon triplet corresponds to positions 8–10.
YMH, which corresponds to tRNA
Tyr, has a UGU
sequence that is an unmodiﬁed form of UQU, at positions
7–9. When 50 labelled YMH was incubated with E5-CRD,
a band of the shorter fragment appeared as shown in
Figure 2A (lanes 1 and 2). Size estimation of this new frag-
ment revealed that the cleavage site was between G8 and U9
(Figure 2B, lanes 1–3, and Figure 2C); this indicated that
YMH is cleaved by E5-CRD in the same manner as tRNA
Tyr.
Consistently, KMH is not cleaved like the original tRNA
Lys
(Figure 2A, lanes 9 and 10) (9). These and the following
results show that YMH is actually cleaved by E5-CRD and
that the anticodon arm is sufﬁcient to be recognized by E5-
CRD. In addition, it was conﬁrmed that the modiﬁcation of
G to Q is not required for colicin E5 action.
Determination of the minimal component of MHs
recognized by E5-CRD
In order to evaluate the signiﬁcance of the UGU sequence,
a variant, YMH(G8A), in which G8 was replaced with A to
obtain purine as the base, was incubated with E5-CRD.
No cleavage product was detected on the polyacrylamide
gel (Figure 2A, lanes 5 and 6). Similarly, YMH(U9C) was
not cleaved (Figure 2A, lanes 7 and 8). On the contrary,
YMH(U7C) was cleaved by E5-CRD to almost the same
extent as YMH (Figure 2A, lanes 3 and 4 versus lanes 1
and 2), and as in the case of YMH, the cleavage occurred
between G8 and U9 (Figure 2B, lanes 4–6). The mutations
at G or the second U of the UGU sequence of YMH abolished
susceptibility to E5-CRD; however, the mutation of the ﬁrst
U, at least to C, did not change the activity at all. These
results suggest that the GU sequence corresponding to ﬁrst
and the second letters of the anticodon triplet is the minimum
requirement for E5-CRD as a target molecule.
In this case, an E5-CRD-resistant tRNA must be converted
to an E5-CRD-sensitive tRNA through a simple replacement
yielding an anticodon GUN (where N is any nucleotide). To
test this hypothesis, we prepared a variant of KMH, namely,
KMH(U8G), in which U has been replaced with G at position
8 to create the GU sequence in the anticodon. When
incubated with E5-CRD and analysed by electrophoresis,
KMH(U8G) was in fact cleaved by E5-CRD (Figure 2A,
lanes 11 and 12) exactly between G8 and U9 (Figure 2B,
lanes 7–9). The extent of the reaction was lower than that
in the case of YMH; this is discussed later. It was possible
to convert an E5-CRD-resistant MH to an E5-CRD-sensitive
MH by introducing a GU sequence into the anticodon, and
conﬁrmed that the GU sequence is the minimal component
recognized by E5-CRD. We determined the optimal condition
for E5-CRD with YMH as a substrate (data not shown),
and adopted 20 mM Tris–HCl, pH 8.5, and 50 mM NaCl
as the basal buffer for the reaction mixture. Under these
conditions, the nonenzymatic cleavage of MHs was not
Figure 1. Minihelices used in this study. Each minihelix (MH) is referred to as XMH where X is the amino acid that is accepted by the parental tRNA. For
example, YMH is the MH mimicking the anticodon arm of tRNA
Tyr. In the models, the top left is the 50 end of each oligoribonucleotide, and each ribonucleotide
is numbered from this position. GGXMH indicates a guanylyl-guanosine that was added at the 50 end of XMH. If ribonucleotide X at position n was changed to
Y, then it is indicated in parentheses as XnY. The horizontal lines indicate the putative H-bonds.
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cations, and is highly heat stable since it retained almost
the same activity after boiling for 15 min at 95 C (data not
shown).
Influence of the nucleotides surrounding the GU
sequence on the cleavage between G and U
In the previous paper (9), we reported that tRNA
Tyr is the
most susceptible tRNA within a cell after the challenge
with colicin E5, and that the order of susceptibility of cyto-
plasmic tRNAs is tRNA
Tyr > tRNA
Asp > tRNA
His, tRNA
Asn.
In order to determine whether the susceptibilities of the
tRNAs reﬂect some local structural features around their anti-
codon arms, we prepared four 19-mer MHs corresponding to
the four tRNAs (GGXMHs in Figure 1), and the cleavage
efﬁciency of these MHs toward E5-CRD was compared.
As shown in Figure 3A, GGYMH was the most susceptible
among the four GGXMHs, and the extent was comparable
with that of the 17mer YMH. The susceptibilities of
GGYMH, GGDMH, GGHMH and GGNMH decreased
gradually in that order; this is consistent with the properties
of the parental tRNAs.
Among the sequence variations of the four GGXMHs, we
presumed that the susceptibility primarily depends on the
30 proximal ribonucleotide of the GU sequence, i.e. A, C, G
or U at position 12 of the 19mer GGXMHs. Then, the suscep-
tibilities of YMH and its variants, in which A10 was replaced
with C, G or U, were compared (Figure 3B). The susceptibil-
ity decreased in the following order: YMH >> YMH(A10C) >
YMH(A10G) > YMH(A10U). The order of susceptibility
among the four YMH variants with only a single nucleotide
change at position 10 was highly comparable with the order
of susceptibility among four GGXMHs with corresponding
anticodons.
Is the susceptibility affected by the ribonucleotide 50
proximal to the GU sequence that is invariably U in all
E.coli tRNAs (19)? We have observed already that
YMH(U7C) is as susceptible to E5-CRD as YMH
(Figure 2A, lanes 3 and 4 versus lanes 1 and 2). Figure 3C
conﬁrms this observation and, furthermore, shows that the
susceptibilities of the other two variants YMH(U7A) and
YMH(U7G) were extremely diminished. This indicates that
E5-CRD exclusively prefers a pyrimidine to a purine ribo-
nucleotide at the 50 side of the GU sequence.
Cleavage of oligoribonucleotides by E5-CRD
The results with the MHs suggested that the substrate speci-
ﬁcity of E5-CRD is determined only by a local sequence,
including the GU sequence, within an anticodon loop. Does
E5-CRD cleave linear RNAs? A YMH variant, YMHL, was
prepared by changing the sequence of the 30 strand of the
stem so as to avoid helix formation. YMHL was found to
be cleaved by E5-CRD; however, the rate was lower than
that in the case of YMH (Figure 3D). The suggestion that a
linear RNA can be a substrate of E5-CRD raised the next
question: does E5-CRD cleave a guanylyl-uridine diribo-
nucleotide as the ultimate structure of GU-containing
sequences? To answer this, four dinucleotides with a 30 phos-
phate, GpUp, ApUp, GpCp and UpGp, and those lacking
30 phosphate, GpU, ApU, GpC and UpG, were incubated
with E5-CRD, and then the products were analysed by HPLC
on a reversed-phase column. Among these, only GpUp was
cleaved by E5-CRD (Figure 4A), yielding 20,30-cyclic GMP
and 30-UMP (Figure 4B). The replacement of the 50 G with
an A or the 30 U with a C as well as the exchange of
Figure 2. The potential of minihelices with wild-type or mutated sequences
to be cleaved by E5-CRD. (A) YMH and KMH (5 mM each) were incubated
with or without 10 nM of E5-CRD in 20 mM Tris–HCl (pH 7.5) and 20 mM
KCl for 15 min at 37 C, and then analysed by electrophoresis on a 20%
polyacrylamide gel containing 7 M urea (lanes 1, 2, 9 and 10, respectively).
The visible mobility pattern was obtained with a FLA-3000 (FUJI FILM).
Lane numbers are shown beneath the picture. The closed triangle indicates
the band of intact MH. If cleavage of a MH occurred, a band of a shorter
fragment appeared (indicated by the open triangle). Variants of YMH and
KMH with a site-directed mutation were also incubated with E5-CRD and
then analysed. Each mutation is indicated above the picture. The asterisk
indicates the 50-labelled G released from KMH and KMH(U8G) on cleavage
between G1 and U2. (B) YMH, YMH(U7C) and KMH(U8G) were incubated
with (lanes 3, 6 and 9, respectively) or without (lanes 1, 4 and 7, respectively)
E5-CRD, and then analysed by electrophoresis. The bands were visualized
with a FLA-3000 (FUJI FILM). Lane numbers are shown beneath the picture.
In lanes 2, 5 and 8, fragments of partially digested YMH, YMH(U7C) and
KMH(U8G) with 40 mM sodium carbonate, pH 9.0, respectively, were
electrophoresed. The asterisk indicates the 50-labelled G released from
KMH(U8G) on cleavage between G1 and U2. (C) Graphical representation of
the putative structure of 50-labelled YMH and the cleavage site by E5-CRD.
Cleavage (as indicated by a closed triangle) occurs between G8 and U9.
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These results indicate that GpUp conserves the same cleavage
speciﬁcity as those in tRNAs. Using the GpUp oligo-
nucleotide as the minimal substrate, we determined the pH
dependence of the kinetic constants of E5-CRD, and revealed
that both kcat and Km increases with pH (Figure 5A and B).
However, the extent of increase in kcat is much higher
than that in Km, and kcat/Km is the highest at pH 9.0
(Figure 5C).
Effect of the presence of ribonucleotide(s)
adjacent to GpUp on cleavage
In the case of an MH, the ribonucleotide contiguous to the
GU sequence signiﬁcantly inﬂuenced the susceptibility. In
order to determine the dependence of the enzymatic activity
on the sequence of substrate RNAs, kinetic constants of
E5-CRD were determined for several oligoribonucleotides
containing the GpU sequence (Table 1). UpGpUpA was, in
fact, the most susceptible among all oligonucleotides studied
here. However, contrary to our expectation, the extent was
almost the same as that of GpUp. UpGpUpA and GpUp
were comparable in their kcat/Km values; however, both kcat
and Km values of UpGpUpA nearly doubled those of
GpUp; this suggested that the susceptibilities of GpUp and
UpGpUpA are not the same intrinsically.
The 30 extension of GpUp with A alone largely decreases
kcat/Km, and the 50 extension with Up by itself does not
improve kcat/Km. In addition, the 50 extension with Ap,
when compared to that with Up, does not decrease the
kcat/Km value as expected from the decreased susceptibility
in terms of the MH (Figure 3C). These results suggest that
the extension of a ribonucleotide to each side of GpUp by
itself do not improve or, in some cases, even diminish the
ability to be cleaved by E5-CRD.
We also examined GpU. However, as seen in Figure 4A,
GpU was not cleaved at all under the condition employed,
as expected. When trinucleotides with the 50 extension
of Up to GpU and GpUp were compared, the kcat/Km of
UpGpU was much smaller than that of UpGpUp, mainly
due to the decrease in the kcat value. These ﬁndings indicate
that the 30 phosphate of GpUp is essential for cleavage by
E5-CRD.
DISCUSSION
We have shown that an MH corresponding to the anticodon
arm of tRNA
Tyr is effectively cleaved by E5-CRD at the
same position where colicin E5 cleaves target tRNAs.
Analysis using various MH derivatives as substrates revealed
the critical role of the GU sequence at the cleavage site,
Figure 3. Time-dependent cleavage of various minihelices by E5-CRD. Various minihelices, summarized in Figure 1, were incubated and the extent of cleavage
was examined at each time. (A) Minihelices GGYMH, GGHMH, GGNMH and GGDMH that mimicking tRNA
Tyr, tRNA
His, tRNA
Asn and tRNA
Asp,
respectively, were used. YMH was used as a control, and it was confirmed that 50 extended two guanine residues do not affect the susceptibility. (B) A mutation
was introduced at A10 of YMH, and the resulting YMH, YMH(A10G), YMH(A10U) and YMH(A10C) were used as substrates. (C) A mutation was introduced
at U7 of YMH, and the resulting YMH, YMH(U7C), YMH(U7A) and YMH(U7G) were used as substrates. (D) YMH and its derivative, YMHL, with the stem
structure broken, were used. Error bars indicate the standard deviation of three independent assays.
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codon (Figure 2). Furthermore, we revealed that the
dinucleotide GpUp is a good substrate that conserves the
recognition properties for E5-CRD. From these ﬁndings,
we concluded that E5-CRD is an ‘RNA restriction enzyme’
that recognizes the GU sequence, preferentially in the anti-
codon loop, discriminating target tRNAs from other tRNAs
(9,20,21). Dinucleotide GpU is barely cleaved by E5-CRD
under the conditions employed in this study, and the 30 phos-
phate of U was shown to be essential in the catalytic reaction
affecting the kcat value.
When MHs were used as substrates of E5-CRD, the
50 pyrimidine to GU was essential (Figure 3C) and the 30 A
to GU was preferred to the 30 C, G and U, with decreasing
susceptibility in that order (Figure 3B), accounting for the
differences in the susceptibility of E.coli tRNAs for Tyr,
His, Asn and Asp. This implies that the tetranucleotide
YGUN (where Y is a pyrimidine and N is any nucleotide)
at  1t o+3 of anticodons mostly determines the susceptibil-
ity of the tRNAs to E5-CRD. The E5-CRD-resistant
KMH could be converted to E5-CRD-sensitive only by a sin-
gle mutation, U8G. However, as described, the cleavage was
not completely comparable to the authentic YMH (Figure 2A,
lanes 11 and 12 versus lanes 1 and 2). This is probably
because the U at the third letter of the anticodon of MH
is the ‘worst’ nucleotide at this position for cleavage by
E5-CRD. In Figure 2A, a lower molecular weight band indi-
cated with an asterisk is shown. This proved to have been
released from the 50 end of KMH(U8G) through cleavage
between G1 and U2 (Figure 2B, lane 9). The same cleavage
at the 50 end was also detected, but only faintly, for the
reaction product of KMH whose anticodon loop is resistant
to E5-CRD (Figure 2A, lanes 9 and 10). We interpreted
that the 50 terminal GU of KMH undergoes only limited dena-
turation, but that of KMH(U8G) becomes single-stranded and
more sensitive to E5-CRD after the cleavage of the anticodon
by E5-CRD.
Then, oligonucleotides were studied in contrast to MHs,
the sequence GpUp was the minimum and almost the best
substrate of E5-CRD that retained its sequence preference
(Table 1). The 50 extension of Up or the 30 extension of
A to GpUp were expected to enhance the susceptibility to
E5-CRD as in the MH. However, they did not increase
kcat/Km. Even UpGpUpA exhibited kcat/Km values comparable
with those of GpUp; although, the kcat and Km values of
UpGpUpA were slightly higher than those of GpUp. On the
contrary, when the 50 Up of UpGpUpA was replaced with the
‘bad’ nucleotide, Ap, the kcat/Km value decreased to only
approximately half the original; this is not consistent with
the drastic decrease in the susceptibility of YMH(U7A)
(Figure 3C). These results suggest that nucleotides contigu-
ous to the GU sequence are not positively involved in and,
in some cases, may even be obstructive to the enzyme-
substrate binding. What causes the inconsistency between
the MHs and the oligonucleotides? The GU sequence within
a loop structure may generally be preferred by E5-CRD to
those within the linear RNA, as suggested in Figure 3D. In
addition, most plausibly, the local conformation around the
GU sequence in the loop, which may vary accoring to the
nucleotides contiguous to GU, plays a role in the variation
of susceptibility. In MHs, the loop is ﬁxed by the stem struc-
ture, and the conformations of both the nucleotides contigu-
ous to GU are limited. On the other hand, both the termini
of an oligonucleotide are free-ended and undergo ﬂexible
conformation changes. This may also cause larger differences
in the effect of changing the nucleotides contiguous to GU on
MHs and oligonucleotides.
As a speciﬁc ﬁxed structure, the U-turn is found in anti-
codon loops of tRNAs (22), tetra loops of GNRA (where N
is any nucleotide and R is a purine nucleotide) (23) and
some other RNA molecules (24–27). The U-turn is a sharp
turn of a phosphate backbone at the conserved U33 of
tRNAs and is reported to contribute to tRNA-ribosome
binding (28,29). The U33 in tRNA
Tyr corresponds to U7 of
YMH used in this study. The drastic loss of susceptibility
to E5-CRD caused by a base change of U7 to A or G of
YMH (Figure 3C) is possibly due to the destruction of the
U-turn fold. However, at present, it cannot be concluded
Figure 4. Cleavage of oligonucleotides by E5-CRD. (A) Various diribonu-
cleotide diphosphates (125 mM) or those lacking 30 phosphate (125 mM) were
incubated with or without 50 nM of E5-CRD for 15 min at 37 C. In order to
stop the reaction, 250 nM of ImmE5 was added. Then, the reaction solutions
were directly applied on a reversed-phase column and the products were
analysed. The upper (Control) and lower (E5-CRD added) charts of each
panel were adjusted for retention times. (B) After the incubation of E5-CRD
and GpUp, the reaction solution was mixed with authentic 30-UMP, 30-GMP
or 20,30-cyclic GMP and applied on the column to compare retention times.
30-UMP and 20,30-cyclic GMP were produced from GpUp by the cleavage
reaction of E5-CRD.
6070 Nucleic Acids Research, 2006, Vol. 34, No. 21that the U-turn is necessary to serve as a good substrate of E5-
CRD,sincethechangeofU7toCalsoretainedthesusceptibility.
Recently, we found that the E5-CRD structural preference for
small RNA loops containing GU was demonstrated by an
in vitro selection method (Y. Harada, T. Ogawa, H. Masaki,
S. Yokoyama and I. Hirao, manuscript in preparation).
When growing E.coli cells were challenged by colicin E5,
QU in the anticodon loop of the target tRNAs was speciﬁc-
ally cleaved, but GU sequences in other parts of the tRNA
molecules were not (9). However, E5-CRD can cleave a
GU in a single-stranded linear RNA (Figure 3D), although
with less efﬁciency, and it also cleaves a GpUp dinucleotide
(Figure 4A). Then, why are the GU sequences in mature
tRNA molecules, other than the QU in anticodons, not
cleaved? Since tRNA molecules are tightly packed, the anti-
codon loop is the only naked part and other single-stranded
parts such as the TYC-loop and D-loop are folded into the
L-shape form. Therefore, we assume that the bases in the
TYC-loop and D-loop are not easily accessible to E5-CRD
from outside the tRNA molecule and only the anticodon
loop is cleaved. We determined recently the tertiary structure
of E5-CRD bound to a substrate analogue dGpdUp by crystal
structure analysis (S. Yajima, S. Inoue, T. Ogawa, T. Nonaka,
K. Ohsawa and H. Masaki, accompanying paper). The active
site forms a narrow cleft on the surface of E5-CRD, to which
smallprotrudingloopssuchastheanticodonlooparesuggested
to ﬁt. In the resolved structure, the nucleotide conformations
are syn and anti for dG and dU, respectively. The guanine has
three hydrogen bonds with Val103, and stacks with the indole
ringofTrp102;whiletheuracilhashydrogenbondswithSer52,
Phe53 and Lys55, and stacks with the pseudo-ring formed by
Asp105 and Arg107 (Figure 6). The Q base of tRNAs was
implicated to extend its modiﬁed group at N7 of G without
interacting with E5-CRD. This is consistent with our observa-
tion that colicin E5 does not distinguish G and Q bases.
The idea that the tight conformation of tRNA molecules
contributes to the anticodon-speciﬁc activity of E5-CRD is
also supported by other ﬁndings. When E5-CRD was incu-
bated with in vitro-transcribed tRNAs devoid of modiﬁed
Figure 5. pH dependence of the kinetic constants of E5-CRD with GpUp as the substrate. (A) kcat values are plotted against pH. (B) Km values are plotted
against pH. (C) kcat/Km values are plotted against pH.
Table 1. Kinetic parameters of E5-CRD towards various oligoribonucleotides
Substrate Km (mM) Kcat (S
 1) Kcat/Km (·10
6 M
 1 S
 1)
GpU ND ND ND
GpUp 32.9 (5.5) 42.9 (3.2) 1.30 (0.13)
UpGpU 143 (38) 3.57 (0.34) 0.0251 (0.0047)
UpGpUp 41.3 (16) 34.0 (3.5) 0.823 (0.23)
GpUpA 53.6 (16) 11.7 (1.1) 0.218 (0.046)
UpGpUpA 59.5 (18) 84.2 (7.1) 1.41 (0.32)
ApGpUpA 90.6 (23) 65.8 (6.4) 0.73 (0.12)
Numbers in parentheses indicate the standard errors obtained from n > 16
experiments. ND, not detected.
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was observed; however, the anticodon loop was the most
sensitive (data not shown). The conformation of the tRNA
molecule is stabilized by the tertiary interactions maintained
by modiﬁed bases (30,31). Therefore, the extra cleavages by
E5-CRD are possibly caused by the less tight conformations
of in vitro-transcribed tRNAs. The ﬁnding that an in vitro-
transcribed tRNA exposes additional recognition sites is
also reported for the recognition of UGU in the anticodon
loop by tRNA-guanine transglycosylase (TGT: 32). Kung
et al. (33) demonstrated that E.coli TGT could recognize
UGU located in the TYC arm of in vitro-transcribed
yeast tRNA
Phe, but not when the wild-type tRNA
Phe with
modiﬁcations was used.
Recently, Lin et al. (34) reported that E5-CRD, which
lacks the N-terminal seven amino acids as compared with
that of our construct, recognizes the GU residues of a sub-
strate MH. Our present results are consistent with those
of the authors; however, we have shown that the dinucleotide
GpUp is the ultimate speciﬁc substrate of E5-CRD. We also
suggested that the nucleotides that extended to both sides of
the GU are not positively involved in binding to E5-CRD;
however, at least in the anticodon stem–loop context, there
appears to be a wide range of preference of nucleotides at
both sides of the GU sequence, which explains the extent
of preference of the four actual tRNA species. The above-
mentioned authors concluded that replacement of the ﬁrst U
of UGU with C decreases the cleavage efﬁciency, but this
is not in agreement with our result (Figure 3C). They carried
out an alanine scan of all acidic and basic residues around the
putative RNA binding cleft of E5-CRD. Furthermore, they
solved the crystal structure of E5-CRD, and the structure
of the anticodon-arm of tRNA
Phe was manually docked
into the cleft of E5-CRD. From these results, they suggested
that D97 and R99, corresponding to D105 and R107 of
E5-CRD constructed by us, respectively, were involved in
the recognition of G34. But, in our model, D105 and R107
contribute to the recognition of U35 by stacking of the
pseudo-ring formed by two residues.
The speciﬁc activity of E5-CRD increases in a basic pH
range, though higher afﬁnity to the substrate GU sequences
is observed under the physiological pH condition as seen in
lower Km values (Figure 5). We are proposing a novel enzym-
atic mechanism accounting for the unique pH dependence
of the reaction (S. Inoue, S. Yajima, T. Ogawa, M. Hidaka
and H. Masaki, manuscript in preparation). In a way, it is
interesting to know that such suboptimal level of the tRNase
activity is sufﬁciently strong for colicin E5 to cleave four tar-
get tRNAs and to cause sensitive cells to die. Why did colicin
E5 acquire such speciﬁcity? In order to possess stronger abil-
ity to kill other cells, it would be favourable if E5-CRD had a
nonspeciﬁc RNase activity instead of such a speciﬁc one.
This is also the case with other RNase-type colicins such as
E3, E4 and E6 that cleave 16S-rRNA at the 49th phosphodi-
ester bond from the 30 end. The other tRNase-type colicin,
namely, colicin D also exhibits a narrow substrate speciﬁcity
that only cleaves tRNA
Arg isoacceptors (35). Anticodon
nuclease (ACNase), found in a naturally isolated E.coli prr
+
strain and activated by T4 phage infection also exhibits
tRNA
Lys-speciﬁc RNase activity (36–38). ACNase, which is
known as a suicidal enzyme, plays a speciﬁc role in killing
the host cells. Recently, Lu et al. (39) revealed that
zymocin—a type of killer toxin produced by the yeast
Kluyveromyces lactis—targets tRNAGlumcm5s2UUC,
tRNALysmcm5s2UUU and tRNA
Glnmcm
5s
2UUG. Why are
these enzymes speciﬁc? It is intriguing to postulate the exis-
tence of some ancestral RNases, the roles of which were spe-
cialized to regulate the expression of certain genes by
cleaving their transcripts. Later, these RNases might have inte-
grated as ribonuclease domains into colicins, ACNase or
zymocin, and have evolved the current features. This hypothe-
sis allows us the supposition of the ‘tRNase family’ of which
these enzymes are members (20). At present, we may be
aware of only some of these enzymes; however, in the future,
we may be able to determine all tRNases.
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